Health Dec 30 FDA criticized for working too closely with biotech company to approve Alzheimer’s drug By Geoff Bennett
Nation Sep 28 Watch 4:06 News Wrap: European Union says it will retaliate against attacks on energy networks In our news wrap Wednesday, the European Union says it will retaliate against attacks on its energy networks after explosions damaged two pipelines in the Baltic Sea, Palestinian authorities say Israeli forces killed four Palestinians and wounded more than 40…
Economy May 03 Biogen to replace CEO after Alzheimer’s drug flops Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers. By Matthew Perrone, Tom Murphy, Associated Press
Health Dec 20 Biogen cuts the price tag on its Alzheimer’s drug in half Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread criticism for an initial cost that can reach $56,000 annually. By Tom Murphy, Associated Press